UMC Governing Board Audit & Finance Committee
Summary
Admissions 9.5% below budget; labor $7.7M over budget; cash on hand 54.1 days.
What Matters to Employees 2 items
$130M outstanding supplemental payments.
Leading clinical trial site; financial benefits shown.
All Agenda Items 15 items
Revenue $12.5M over budget, expenses $9.5M over.
On track; budget details discussed; risk mitigation in place.
Income goal $2.9M below budget; ALOS target not met.
Admissions -9.5%; labor +$7.7M; cash on hand 54.1 days.
No impact to UMC; private hospitals may face 15% fee.
Ratification for anesthesia/ortho reimbursement.
Adds orthopedic and anesthesia professional fees.
Extends term 24 months; updates reimbursement.
Adds orthopedic and anesthesia professional services.
Extends term; increases NTE for renovation projects.
Sole respondent; 3-year term with extensions.
Increases funding for pest control at new locations.
Approval to purchase property; closing pending.
Adds pancreas transplant; increases funding due to volume.
Additional space, parking, extended term to 2028.